JOSEPH F KASPER

Allopathic & Osteopathic Physicians|Family Medicine FORT HUACHUCA, AZ NPI 1972581528

General Payments — all program years on this page

$339.94

  • Category: General Payments
  • Program years: PY2019–2020
  • Record count: 25
  • As of (CMS publication): 2026-01-23

Latest program year (PY2020): $270.39 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2020) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $270.3920

By paying entity

Latest program year (PY2020) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $69.555
2020 $270.3920

Records — PY2020 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
720540631 Boehringer Ingelheim Pharmaceuticals, Inc. $15.02 05/15/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
725332573 Boston Scientific Corporation $12.88 02/20/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
728504051 Lilly USA, LLC $16.86 07/31/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
735784899 AstraZeneca Pharmaceuticals LP $14.40 05/19/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
735904393 AstraZeneca Pharmaceuticals LP $11.67 02/13/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736175573 AstraZeneca Pharmaceuticals LP $14.37 05/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736244351 AstraZeneca Pharmaceuticals LP $17.30 05/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736455991 AstraZeneca Pharmaceuticals LP $11.39 03/23/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
737551921 Salix Pharmaceuticals, a division of Bausch Health US, LLC $12.27 01/24/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
737551923 Salix Pharmaceuticals, a division of Bausch Health US, LLC $11.27 02/24/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744555849 Novo Nordisk Inc $12.45 01/14/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744753659 Novo Nordisk Inc $15.35 06/23/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744808789 Novo Nordisk Inc $12.46 07/29/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
748590843 Sunovion Pharmaceuticals Inc. $12.39 05/04/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
748590845 Sunovion Pharmaceuticals Inc. $14.92 07/01/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
748590847 Sunovion Pharmaceuticals Inc. $15.36 03/30/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
748590849 Sunovion Pharmaceuticals Inc. $15.41 02/25/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
748737603 Otsuka America Pharmaceutical, Inc. $11.16 02/15/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
748737607 Otsuka America Pharmaceutical, Inc. $11.58 07/09/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
749341969 Adlon Therapeutics L.P. $11.88 03/09/2020 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.